Sections News

Alcohol Treatment Matrix

Thursday, 03 April 2014 09:11

An innovative way of presenting evidence on alcohol treatment has been praised by several BSG members - the 'Go to Matrix' which presents a lot of clinical information in a clear way:

The Alcohol Treatment Matrix is concerned with the treatment of alcohol-related problems among adults (another deals with drug-related problems). It maps the treatment universe and for each sub-territory (a cell) lists the most important UK-relevant research and guidance. Across the top, columns move from specific interventions through how their impacts are affected by the widening contexts of practitioners, management, the organisation, and whole local area treatment systems. Down the rows are the major intervention types implemented at these levels. Inside each cell is our pick of the most important documents relevant to the impact of that intervention type at that contextual level. Visit the matrices page for articles, presentations, and a video explaining their genesis and construction.

Public Health Research project 09/3001/09 report published:

Wednesday, 06 November 2013 10:01

"Reducing alcohol-related harm in disadvantaged men: development and feasibility assessment of a brief intervention delivered by mobile telephone, Public Health Research".

MRC Public Health Intervention Development Scheme (PHIND)

Wednesday, 06 November 2013 09:57

The Public Health Intervention Development scheme (PHIND) is a new MRC funding scheme designed specifically to provide support for early phase development of public health interventions. This rapid response funding scheme is aimed at improving the initial evidence on which the development and evaluation of public health interventions are based. Studies should address an important UK or global public health issue and offer an innovative approach to intervention development or applying an existing intervention in a new setting.

The scheme's remit ranges from primary research developing and designing the intervention to feasibility studies, encompassing:

  • developing theory
  • modelling process and outcomes
  • assessing feasibility

Systematic reviews, meta analyses and pilot studies are outside the remit of the PHIND scheme. Applicants can apply for up to £150K for a maximum of 18 months and the scheme will operate three times a year. For further information, please see the MRC website.

BSG Response to Consultation on the Government's Alcohol Strategy

Thursday, 07 February 2013 17:52

Tom Smith, BSG Chief Executive

The British Society of Gastroenterology is continuing to lobby in the interests of our members, and patients, across gastroenterology and hepatology. As I am sure you are aware, the Government is currently consulting on their Alcohol Strategy which includes provision for a minimum unit price for alcohol of 45p. The BSG is working closely with partners in the Alcohol Health Alliance (AHA) to ensure that this minimum unit price is brought into action and that it is set at the more effective price of 50p. This is a significant moment in the push for measures to deal with the increasing problems that alcohol poses to the nation's health and we must seize on the opportunity to demonstrate the widespread support of health professionals for these measures. The BSG & AHA have submitted their responses. (The BSG response may be viewed via the link below).

NICE Alcohol Evidence Update 2013

Thursday, 07 February 2013 16:34

'Alcohol use disorders: harmful drinking and alcohol dependence Evidence Update January 2013'

NICE has released a summary of selected new evidence relevant to its clinical guideline 'Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence' (2011)

Evidence Updates provide a summary of selected new evidence published since the literature search was last conducted for the accredited guidance they relate to. They reduce the need for individuals, managers and commissioners to search for new evidence. Evidence Updates highlight key points from the new evidence and provide a commentary describing its strengths and weaknesses. They also indicate whether the new evidence may have a potential impact on current guidance. For contextual information, this Evidence Update should be read in conjunction with the relevant clinical guideline, available from the NHS Evidence topic page for alcohol.

Page 2 of 4